Table 1.
Clinical findings of patients with Guillain-Barre syndrome (GBS) at the time of the diagnosis
| Clinical findings | Percentage | |
|---|---|---|
| Pain | 15.6 | |
| Cranial nerve involvement | Facial | 23.2 |
| Bulbar | 14.7 | |
| Ophthalmic | 4.5 | |
| Sensory involvement | Sensory level | 3.9 |
| Hypoesthesia | 2.3 | |
| Paresthesia | 8.6 | |
| Autonomic dysfunction | Blood pressure rising | 3.1 |
| bladder dysfunction | 4.0 | |
| Tachycardia | 3.9 | |
| Bradycardia | 0.8 | |
| Hypotension | 0.8 | |
| History of previous infection | No infection | 48.4 |
| Upper respiratory tract infection | 34.4 | |
| Gastroenteritis | 14.1 | |
| Vaccination | 1.6 | |
| Other infection | 1.6 | |
| NCS study | AIDP | 70.3 |
| AMAN | 5.5 | |
| AMSAN | 7.8 | |
| Normal | 7.0 | |
| Other | 9.4 | |
NCS: Nerve conduction study; AIDP: Acute inflammatory demyelinating polyneuropathy; AMAN: Acute motor axonal neuropathy; AMSAN: Acute motor sensory axonal neuropathy